Population expansion, clonal growth, and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF alpha in a chemically defined (HGM … GD Block, J Locker, WC Bowen, BE Petersen, S Katyal, SC Strom, T Riley, ... The Journal of cell biology 132 (6), 1133-1149, 1996 | 662 | 1996 |
Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease N Khov, A Sharma, TR Riley World journal of gastroenterology: WJG 20 (22), 6821, 2014 | 207 | 2014 |
A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. TR Riley, RE Schoen, RG Lee, J Rakela American Journal of Gastroenterology (Springer Nature) 92 (2), 1997 | 142 | 1997 |
Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series TR Riley III, JP Smith Official journal of the American College of Gastroenterology| ACG 93 (9 …, 1998 | 117 | 1998 |
Preventive strategies in chronic liver disease: part II. Cirrhosis TR RILEY III, AM Bhatti American family physician 64 (10), 1735-1741, 2001 | 101 | 2001 |
Independent of cirrhosis, hepatocellular carcinoma risk is increased with diabetes and metabolic syndrome AJ Kasmari, A Welch, G Liu, D Leslie, T McGarrity, T Riley The American journal of medicine 130 (6), 746. e1-746. e7, 2017 | 98 | 2017 |
Preventive strategies in chronic liver disease: part I. Alcohol, vaccines, toxic medications and supplements, diet and exercise TR RILEY III, AM Bhatti American family physician 64 (9), 1555-1561, 2001 | 94 | 2001 |
How often does ultrasound marking change the liver biopsy site? TR Riley III Official journal of the American College of Gastroenterology| ACG 94 (11 …, 1999 | 82 | 1999 |
Peloisis hepatis due to Bartonella henselae in transplantation: a hemato-hepato-renal syndrome N Ahsan, MJ Holman, TR Riley, CS Abendroth, EG Langhoff, HC Yang Transplantation 65 (7), 1000-1003, 1998 | 65 | 1998 |
Association of direct-acting antiviral treatment with mortality among medicare beneficiaries with hepatitis C Y Kalidindi, J Jung, R Feldman, T Riley JAMA network open 3 (7), e2011055-e2011055, 2020 | 53 | 2020 |
Preventive care in chronic liver disease TR Riley, JP Smith Journal of general internal medicine 14, 699-704, 1999 | 50 | 1999 |
Predictors of pain medication use after percutaneous liver biopsy TR Riley Digestive diseases and sciences 47, 2151-2153, 2002 | 48 | 2002 |
Lactulose-induced pneumatosis intestinalis and pneumoperitoneum RA Goodman, TR Riley 3rd Dig Dis Sci 46 (46), 2549-53, 2001 | 44 | 2001 |
Amantadine therapy for chronic hepatitis C: a dose escalation study JP Smith, TR Riley III, S Bingaman, DT Mauger Official journal of the American College of Gastroenterology| ACG 99 (6 …, 2004 | 36 | 2004 |
Impact of geographic disparity on liver allocation for hepatocellular cancer in the United States Z Kadry, EW Schaefer, T Uemura, AR Shah, I Schreibman, TR Riley III Journal of hepatology 56 (3), 618-625, 2012 | 35 | 2012 |
Bedside ultrasound can predict nonalcoholic fatty liver disease in the hands of clinicians using a prototype image TR Riley, A Mendoza, MA Bruno Digestive diseases and sciences 51, 982-985, 2006 | 35 | 2006 |
Can one predict when ultrasound will be useful with percutaneous liver biopsy? M Ahmad, TR Riley III The American journal of gastroenterology 96 (2), 547-549, 2001 | 32 | 2001 |
Amantadine therapy for chronic hepatitis C: A randomized double-blind placebo-controlled trial JP Smith, TR Riley, A Devenyi, SI Bingaman, A Kunselman Journal of general internal medicine 19, 662-668, 2004 | 30 | 2004 |
NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH JG Stine, IR Schreibman, AJ Faust, J Dahmus, B Stern, C Soriano, ... Hepatology 76 (1), 172-185, 2022 | 29 | 2022 |
Immune functional assay for immunosuppressive management in post‐transplant malignancy T Uemura, TR Riley, A Khan, C Hollenbeak, I Schreibman, N Ghahramani, ... Clinical transplantation 25 (1), E32-E37, 2011 | 29 | 2011 |